MicuRx Pharmaceuticals, Inc.
Biotechnology ResearchCalifornia, United States51-200 Employees
MicuRx Pharmaceuticals is a biotechnology company based out of Foster City, California USA and Shanghai, China.
Innovative R&D MicuRx Pharmaceuticals has received recognition as one of the top pharmaceutical innovation research teams, highlighting its strong focus on cutting-edge drug development, particularly in antimicrobial therapeutics, which presents opportunities for partnerships in novel treatment areas.
Expanding Clinical Efforts The company is actively involved in presenting clinical and preclinical research at major industry events like ESCMID Global 2025, indicating ongoing product development and potential readiness for clinical collaborations or early adoption agreements.
Strong Investment Backing With a significant Series E funding round of 700 million yuan led by Legend Capital, MicuRx has substantial financial resources to support expansion, making it an appealing partner for commercialization and distribution agreements.
Recognized Product Innovation MicuRx’s ConteZolid tablets have been awarded for their technological and market potential, suggesting a viable entry point for healthcare providers and distributors aiming to offer innovative health solutions.
Market Focus and Growth Operating in the biotechnology sector with revenues between $50M and $100M and a growing research profile, MicuRx offers opportunities for scaling and strategic alliances within the antimicrobial and infectious disease treatment markets.
MicuRx Pharmaceuticals, Inc. uses 8 technology products and services including WordPress, Google Fonts API, yepnope.js, and more. Explore MicuRx Pharmaceuticals, Inc.'s tech stack below.
| MicuRx Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@micurx.com | 47% |
| First@micurx.com | 4% |
| Last@micurx.com | 2% |
| FLast@micurx.com | 47% |
Biotechnology ResearchCalifornia, United States51-200 Employees
MicuRx Pharmaceuticals is a biotechnology company based out of Foster City, California USA and Shanghai, China.
MicuRx Pharmaceuticals, Inc. has raised a total of $107M of funding over 8 rounds. Their latest funding round was raised on Dec 21, 2020 in the amount of $107M.
MicuRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M
MicuRx Pharmaceuticals, Inc. has raised a total of $107M of funding over 8 rounds. Their latest funding round was raised on Dec 21, 2020 in the amount of $107M.
MicuRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M